Jump Financial, LLC Assembly Biosciences, Inc. Transaction History

Jump Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$1.46 - $2.45 $29,638 - $49,735	-20,300 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$2.13 - $3.46 $43,239 - $70,238	20,300 New	20,300 $47,000
Q1 2021 May 17, 2021	SELL	$4.33 - $6.63 $156,313 - $239,343	-36,100 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$4.87 - $17.29 $175,807 - $624,169	36,100 New	36,100 $218,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $714M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.